This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Mortality data

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

There is a dose-dependent increase in mortality in patients with coronary artery disease who take nifedipine.

Meta-analysis of 16 trials yielded the following risk ratios for total mortality in patients with coronary artery disease taking various doses of nifedipine:

  • Dose per day; Risk ratio for death with 95% CI
  • dose = 30-50 mg; RR = 1.06 (0.89-1.27)
  • dose = 60 mg; RR = 1.18 (0.93-1.50)
  • dose = 80 mg; RR = 2.83 (1.35-5.93)

The authors concluded that high doses of short-acting nifedipine should not be used in patients with coronary artery disease.

Reference:

  • Furberg, CD., Psaty, BM. & Meyer, JV. (1996). Nifedipine. Dose-related increase in mortality in patient with coronary heart disease. Circulation, 92(5), 1326-31.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.